PharVision Advisers’s CF Industries CF Stock Holding History

PharVision Advisers’s Portfolio CF Stock Details CF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,380	Closed	-$261K	–	199
2025 Q4	$261K	Sell	3,380 -1,281	-27%	-$105K	0.13%	364
2025 Q3	$418K	Buy	+4,661	New	+$416K	0.24%	65

Other funds holding CF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's CF Position: Q1 2026 in Review

PharVision Advisers sold out of CF Industries (CF) in Q1 2026, closing a stake of 3,380 shares — an estimated $261K sold.

PharVision Advisers first reported a position in CF in Q3 2025 and held it in 2 quarters. The position peaked at $418K in Q3 2025. 916 funds tracked by Wall St. Rank hold CF as of Q1 2026.

PharVision Advisers reported no remaining CF Industries position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,380 CF Industries shares in Q1 2026, an estimated $261K.
PharVision Advisers first reported a position in CF Industries in Q3 2025 and held it in 2 quarters.
PharVision Advisers's CF Industries position peaked at $418K in Q3 2025.
916 funds tracked by Wall St. Rank held CF Industries as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.